Abbott Medical Devices Trading (Shanghai) Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)

Completed

Conditions: Coronary Disease

Interventions: Device: Multilink Vision™ Stent (CE-labeled)

First Posted Date: 2005-10-24

Last Posted Date: 2009-01-28

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 1300

Registration Number: NCT00243438

Locations: 🇩🇪
Kerckhoff-Klinik, Bad Nauheim, Germany

Feasibility Study of a Percutaneous Mitral Valve Repair System.

Phase 1

Completed

Conditions: Mitral Valve Regurgitation
Mitral Valve Insufficiency
Mitral Valve Incompetence
Mitral Regurgitation
Mitral Insufficiency

Interventions: Device: Percutaneous mitral valve repair (MitraClip Implant)

First Posted Date: 2005-09-21

Last Posted Date: 2018-11-07

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 55

Registration Number: NCT00209339

Locations: 🇺🇸
Evanston Northwestern Healthcare, Evanston, Illinois, United States

Pivotal Study of a Percutaneous Mitral Valve Repair System

Not Applicable

Completed

Conditions: Mitral Valve Incompetence
Mitral Valve Regurgitation
Mitral Regurgitation
Mitral Insufficiency
Mitral Valve Insufficiency

Interventions: Procedure: Mitral valve repair or replacement surgery
Device: Percutaneous mitral valve repair using MitraClip implant

First Posted Date: 2005-09-21

Last Posted Date: 2018-11-07

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 279

Registration Number: NCT00209274

Locations: 🇺🇸
Evanston Northwestern Healthcare, Evanston, Illinois, United States

Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients

Not Applicable

Completed

Conditions: Heart Failure
Ventricular Dyssynchrony

First Posted Date: 2005-09-16

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Registration Number: NCT00187265

Locations: 🇫🇷
Department of Cardiology - CHU Pontchaillou, Rennes, France

B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure Patients

Not Applicable

Completed

Conditions: Ventricular Dysfunction
Heart Diseases
Heart Failure

First Posted Date: 2005-09-16

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Registration Number: NCT00187213

Locations: 🇫🇷
Department of Cardiology - CHU Pontchaillou, Rennes, France

ACTION - Anticoagulation Treatment Influence on Post-operative Patients

Phase 4

Withdrawn

Conditions: Heart Valve Disease

First Posted Date: 2005-09-16

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Registration Number: NCT00187304

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Phase 3

Completed

Conditions: Stents
Coronary Artery Disease
Total Coronary Occlusion
Coronary Artery Restenosis
Stent Thrombosis
Vascular Disease
Myocardial Ischemia
Coronary Artery Stenosis

Interventions: Device: XIENCE V® Everolimus Eluting Coronary Stent
Device: TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent

First Posted Date: 2005-09-16

Last Posted Date: 2011-11-23

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 1002

Registration Number: NCT00180479

Locations: 🇺🇸
North Mississippi Medical Center, Tupelo, Mississippi, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
St. Patrick Hospital, Missoula, Montana, United States

and more 61 locations

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Phase 3

Completed

Conditions: Coronary Disease
Coronary Artery Disease
Coronary Restenosis

Interventions: Device: XIENCE V® Everolimus Eluting Coronary Stent
Device: TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent

First Posted Date: 2005-09-16

Last Posted Date: 2011-07-20

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 300

Registration Number: NCT00180310

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇧🇪
C.H.U. de Liège Sart Tilman, Liège, Belgium
🇧🇪
A.Z. Middelheim, Antwerpen, Belgium

and more 29 locations

SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

Phase 3

Completed

Conditions: Coronary Artery Disease
Everolimus
Vascular Disease
Myocardial Ischemia
Coronary Artery Stenosis

Interventions: Device: Coronary artery drug eluting stent placement
Device: Coronary artery stent placement

First Posted Date: 2005-09-16

Last Posted Date: 2010-01-06

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 60

Registration Number: NCT00180453

Locations: 🇳🇱
Academisch Medisch Centrum, Amsterdam, Netherlands
🇩🇰
Skejby Sygehus, Aarhus, Denmark
🇩🇪
Herzzentrum Bad Oeynhausen, Bad Oeynhausen, Germany

and more 4 locations

Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE

Not Applicable

Completed

Conditions: Atherosclerotic Disease, Carotid

First Posted Date: 2005-09-16

Last Posted Date: 2008-10-29

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 1500

Registration Number: NCT00180492

Locations: 🇺🇸
Guidant Corporation, Santa Clara, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy